Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland

References

• Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 2003; 119; 801–6.
   PubMed Web of Science ®Google Scholar
• Lubahn DB, Joseph DR, Sar M, et al The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol (Baltimore, Md) 1988; 2; 1265–75.
   PubMed Web of Science ®Google Scholar
• Shang Y, Myers M, Brown M. Formation of the androgen receptor transcription complex. Mol Cell 2002; 9; 601–10.
   PubMed Web of Science ®Google Scholar
• Callewaert L, Christiaens V, Haelens A, Verrijdt G, Verhoeven G, Claessens F. Implications of a polyglutamine tract in the function of the human androgen receptor. Biochem Biophys Res Commun 2003; 306; 46–52.
   PubMed Web of Science ®Google Scholar
• Kang Z, Janne OA, Palvimo JJ. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol (Baltimore, Md) 2004; 18; 2633–48.
   PubMed Web of Science ®Google Scholar
• Henshall SM, Quinn DI, Lee CS, et al Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res 2001; 61; 423–7.
   PubMed Web of Science ®Google Scholar
• Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 2004; 28; 928–34.
   PubMed Web of Science ®Google Scholar
• Koivisto P, Kononen J, Palmberg C, et al Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997; 57; 314–9.
   PubMed Web of Science ®Google Scholar
• Ricciardelli C, Jackson MW, Choong CS, et al Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential. Prostate 2008; 68; 830–8.
   PubMed Web of Science ®Google Scholar
• Edwards J, Krishna NS, Witton CJ, Bartlett JM. Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin Cancer Res 2003; 9; 5271–81.
   PubMed Web of Science ®Google Scholar
• Tilley WD, Buchanan G, Hickey TE, Bentel JM. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 1996; 2; 277–85.
   PubMed Web of Science ®Google Scholar
• Lu J, Danielsen M. A Stu I polymorphism in the human androgen receptor gene (AR). Clin Genet 1996; 49; 323–4.
   PubMed Web of Science ®Google Scholar
• Medeiros R, Vasconcelos A, Costa S, et al Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet 2003; 141; 91–6.
   PubMedGoogle Scholar
• Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999; 5; 280–5.
   PubMed Web of Science ®Google Scholar
• Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci USA 1999; 96; 5458–63.
   PubMed Web of Science ®Google Scholar
• Hobisch A, Eder IE, Putz T, et al Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 1998; 58; 4640–5.
   PubMed Web of Science ®Google Scholar
• De Miguel F, Lee SO, Onate SA, Gao AC. Stat3 enhances transactivation of steroid hormone receptors. Nucl Recept 2003; 1; 3.
   PubMedGoogle Scholar
• Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 2007; 120; 719–33.
   PubMed Web of Science ®Google Scholar
• Spencer TE, Jenster G, Burcin MM, et al Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997; 389; 194–8.
   PubMed Web of Science ®Google Scholar
• Chakravarti D, LaMorte VJ, Nelson MC, et al Role of CBP/P300 in nuclear receptor signalling. Nature 1996; 383; 99–103.
   PubMed Web of Science ®Google Scholar
• Blanco JC, Minucci S, Lu J, et al The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev 1998; 12; 1638–51.
   PubMed Web of Science ®Google Scholar
• Korzus E, Torchia J, Rose DW, et al Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 1998; 279; 703–7.
   PubMed Web of Science ®Google Scholar
• Yoon HG, Wong J. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol Endocrinol (Baltimore, Md) 2006; 20; 1048–60.
   PubMed Web of Science ®Google Scholar
• Williams MD, Roberts D, Blumenschein GR, Jr et al Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol 2007; 31; 1645–52.
   PubMed Web of Science ®Google Scholar
• Gregory CW, He B, Johnson RT, et al A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 2001; 61; 4315–9.
   PubMed Web of Science ®Google Scholar
• Debes JD, Sebo TJ, Lohse CM, Murphy LM, Haugen DA, Tindall DJ. p300 in prostate cancer proliferation and progression. Cancer Res 2003; 63; 7638–40.
   PubMed Web of Science ®Google Scholar
• Aaronson DS, Muller M, Neves SR, et al An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells. Mol Cell Endocrinol 2007; 270; 50–6.
   PubMed Web of Science ®Google Scholar
• Freitas LL, Araujo VC, Martins MT, Chone C, Crespo A, Altemani A. Biomarker analysis in carcinoma ex pleomorphic adenoma at an early phase of carcinomatous transformation. Int J Surg Pathol 2005; 13; 337–42.
   PubMed Web of Science ®Google Scholar
• Muller S, Vigneswaran N, Gansler T, Gramlich T, DeRose PB, Cohen C. c-erbB-2 oncoprotein expression and amplification in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: relationship to prognosis. Mod Pathol 1994; 7; 628–32.
   PubMed Web of Science ®Google Scholar
• Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu 1993; 28 Pt 1; 279–328.
   PubMedGoogle Scholar
• Miyoshi Y, Uemura H, Fujinami K, et al Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients. Prostate 2000; 43; 225–32.
   PubMed Web of Science ®Google Scholar
• Cho KS, Lee JS, Cho NH, Park K, Ham WS, Choi YD. Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer. Prostate 2008; 68; 803–8.
   PubMed Web of Science ®Google Scholar
• Brown RS, Edwards J, Dogan A, et al Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. J Pathol 2002; 198; 237–44.
   PubMed Web of Science ®Google Scholar
• Lin DL, Whitney MC, Yao Z, Keller ET. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin Cancer Res 2001; 7; 1773–81.
   PubMed Web of Science ®Google Scholar
• Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 2001; 116; 452–5.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Nomoto M, Yonezawa S, et al Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients. Biochem Biophys Res Commun 2004; 321; 468–71.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Karube A, Karube Y, et al GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients. Biochem Biophys Res Commun 2005; 329; 100–4.
   PubMed Web of Science ®Google Scholar